Cunningham Daniel, LaRose Micaela, Kinamon Tori, MacAlpine Elle, Au Sandra, Paniagua Ariana, Klifto Christopher, Gage Mark J
Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.
Duke University School of Medicine, Duke University Medical Center, NC, USA.
J Plast Surg Hand Surg. 2023 Feb-Dec;57(1-6):299-307. doi: 10.1080/2000656X.2022.2070178. Epub 2022 May 11.
Regional anesthesia (RA) is commonly used in distal radius fracture surgery to reduce pain and opioid consumption. The purpose of this study was to evaluate the real-world impact of RA on inpatient and outpatient opioid consumption and demand in patients undergoing distal radius fracture surgery.
All patients ages 18 and older undergoing distal radius fracture surgery between 7/2013 and 7/2018 at a single institution ( = 969) were identified. Inpatient opioid consumption and outpatient opioid prescribing in oxycodone 5-mg equivalents (OE's) up to 90-d post-operative were recorded for patients with and without RA. Adjusted models were used to evaluate the impact of RA on opioid outcomes.
Adjusted models demonstrated decreases in inpatient opioid consumption in patients with RA (10.7 estimated OE's without RA 7.6 OE's with RA from 0 to 24 h post-op, 10.2 5.3 from 24 to 48 h post-op and 7.5 5.0 from 48 to 72 h post-op, <.05). Estimated cumulative outpatient opioid demand was significantly higher in patients with RA (65.3 OE's without RA 81.0 with RA from 1-month pre-op to 2-week post-discharge, 76.1 87.7 OE's to 6-weeks, and 80.8 93.5 OE's to 90-d, all values for RA <.05) though rates of refill were significantly lower in patients with RA from 2-week to 6-week post-op compared to patients without RA.
Patients undergoing RA in distal radius fracture surgery had decreased inpatient opioid consumption but increased outpatient demand after adjustment for patient and operative characteristics.
Level III, retrospective, therapeutic cohort study.
区域麻醉(RA)常用于桡骨远端骨折手术,以减轻疼痛和减少阿片类药物的使用。本研究的目的是评估RA对接受桡骨远端骨折手术患者的住院和门诊阿片类药物使用及需求的实际影响。
确定了2013年7月至2018年7月在单一机构接受桡骨远端骨折手术的所有18岁及以上患者(n = 969)。记录了有和没有RA的患者术后90天内以5毫克羟考酮等效物(OE's)计算的住院阿片类药物使用量和门诊阿片类药物处方量。使用校正模型评估RA对阿片类药物结果的影响。
校正模型显示,RA患者的住院阿片类药物使用量减少(术后0至24小时,无RA患者估计为10.7 OE's,有RA患者为7.6 OE's;术后24至48小时,10.2对5.3;术后48至72小时,7.5对5.0,P <.05)。RA患者的估计累积门诊阿片类药物需求量显著更高(术前1个月至出院后2周,无RA患者为65.3 OE's,有RA患者为81.0;至6周时,76.1对87.7 OE's;至90天时,80.8对93.5 OE's,RA的所有P值<.05),尽管与无RA患者相比,RA患者术后2周内至6周的再填充率显著更低。
在调整患者和手术特征后,接受RA的桡骨远端骨折手术患者的住院阿片类药物使用量减少,但门诊需求量增加。
III级,回顾性,治疗性队列研究。